EW vs MAS stock comparison
Edwards Lifesciences vs. Masco · data as of November 13, 2026
Edwards Lifesciences (EW) has a market value of about $61.6B, Masco (MAS) about $16.3B. Over their latest twelve months Edwards Lifesciences had revenue of $6.7B and Masco $7.7B.
On our five checks Edwards Lifesciences scores higher: 2.8 out of 5 (average) against 2.6 (average).
By area, the stronger company is Masco on value; Edwards Lifesciences on future growth; Edwards Lifesciences on financial health; Masco on shareholder returns.
Masco is cheaper on earnings (P/E 18.3 vs. 60.5), while Edwards Lifesciences grew revenue faster over five years (6.7% vs. 1.0% a year).
Edwards Lifesciences leads on 12 of the compared lines and Masco on 11.
Side by side
| EW | MAS | |
|---|---|---|
| Size and price | ||
| Market cap | $61.6B | $16.3B |
| Share price | $107.15 | $84.68 |
| Score | ||
| Overall score (of 5) | 2.8 | 2.6 |
| Value | 0 | 3 |
| Future growth | 4 | 1 |
| Track record | 2 | 2 |
| Financial health | 5 | 2 |
| Shareholder returns | 3 | 5 |
| Valuation | ||
| P/E (TTM) | 60.5 | 18.3 |
| Forward P/E | 33.5 | 19.8 |
| Price / free cash flow | 43.3 | 15.7 |
| Price / sales | 9.2 | 2.1 |
| EV / EBITDA | 35.8 | 12.6 |
| PEG | 8.55 | — |
| DCF value vs. price | −64% | −11% |
| Business | ||
| Revenue | $6.7B | $7.7B |
| Net income | $1.0B | $926M |
| Free cash flow | $1.4B | $1.0B |
| Net margin | 15.3% | 12.1% |
| Gross margin (5-yr avg.) | 79.6% | 34.5% |
| ROIC (5-yr avg.) | 16.0% | 33.1% |
| Growth | ||
| Revenue growth (1 yr) | 11.6% | -3.4% |
| Revenue growth (5 yrs, per year) | 6.7% | 1.0% |
| EPS growth (5 yrs, per year) | 7.1% | -3.4% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | $3.9B | -$2.9B |
| Dividend yield | None | 1.51% |
| Shareholder yield | 1.5% | 5.0% |
| Analysts | ||
| Upside to average target | +6% | −2% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: EW TTM to September 30, 2026, MAS TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Edwards Lifesciences or Masco?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Edwards Lifesciences scores 2.8 out of 5 and Masco 2.6; the table shows where each one is stronger.
Is Edwards Lifesciences cheaper than Masco?
On trailing earnings, Masco trades at a P/E of 18.3 and Edwards Lifesciences at 60.5, so Masco is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Edwards Lifesciences or Masco?
Over five years Edwards Lifesciences grew revenue about 6.7% a year and Masco about 1.0% a year.
Which pays a higher dividend?
Edwards Lifesciences yields nothing (no dividend) and Masco 1.51%.
Full Edwards Lifesciences analysis → Full Masco analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.